Natixis Lowers Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Natixis lowered its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 98.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 451 shares of the medical device company's stock after selling 24,007 shares during the quarter. Natixis' holdings in Cooper Companies were worth $41,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. JPMorgan Chase & Co. increased its stake in Cooper Companies by 1.5% during the 4th quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company's stock valued at $460,066,000 after purchasing an additional 74,501 shares in the last quarter. Geode Capital Management LLC lifted its position in Cooper Companies by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company's stock valued at $449,907,000 after purchasing an additional 109,907 shares during the period. Victory Capital Management Inc. boosted its holdings in Cooper Companies by 14.6% in the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after purchasing an additional 574,899 shares during the last quarter. Norges Bank acquired a new stake in Cooper Companies during the 4th quarter worth about $217,906,000. Finally, FMR LLC raised its stake in shares of Cooper Companies by 97.6% during the 4th quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock valued at $203,911,000 after buying an additional 1,095,805 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Cooper Companies Price Performance

COO stock traded up $0.38 during midday trading on Tuesday, reaching $82.23. The stock had a trading volume of 1,156,744 shares, compared to its average volume of 1,424,626. The Cooper Companies, Inc. has a 52-week low of $69.81 and a 52-week high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The company's fifty day simple moving average is $82.04 and its 200 day simple moving average is $92.41. The company has a market cap of $16.44 billion, a price-to-earnings ratio of 42.17, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. As a group, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on COO. Robert W. Baird decreased their price target on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. Stifel Nicolaus decreased their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th. Piper Sandler reaffirmed an "overweight" rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Finally, BNP Paribas raised Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of "Moderate Buy" and an average price target of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.